top of page
Search
  • biolabs-marketing

stem cell markers

With the similar properties with human embryonic stem cells (hESCs) both at molecular and functional levels, human induced pluripotent stem cells (hiPSCs) are considered to be potential for drug screening, disease modeling, and regenerative medicine. Now, hiPSCs can be generated from different somatic cell types by overexpressing four transcription factors (OCT4, SOX2, KLF4, and MYC). However, there is a major limitation during reprogramming process that low efficiency in pluripotency induction leads to the generation of a few reprogrammed hiPSCs. Although the morphology analysis of iPSCs has been used for their isolation, some studies have shown that the isolated hiPSC clones have differences in the expression of pluripotency gene markers and those with the similar levels of pluripotency marker expression present different abilities in lineage differentiation. In this case, the analysis of pluripotency gene marker expression would be a potential strategy for the enrichment and isolation of iPSCs.

Read Full Article: stem cell markers

0 views0 comments

Recent Posts

See All

adc conjugate

Monoclonal antibody-based immunotherapies against cancer and other infectious diseases are highly advantageous comparing to conventional...

Knock-out Models

With the emerging techniques of mouse genome modification, transgenic mice have become a powerful tool for modeling human disease and the...

Comments


bottom of page